STRUCTURE-BASED DRUG DESIGN METHODS FOR IDENTIFYING DALA-D-ALA LIGASE INHIBITORS AS ANTIBACTERIAL DRUGS

Details for Australian Patent Application No. 2002320184 (hide)

Owner PLIVA, D., D. ESSENTIAL THERAPEUTICS, INC.

Inventors NAVIA, Manuel, A.; GRIFFITH, James, P.; FAERMAN, Carlos, H.; MAGEE, Andrew, S.; PEROLA, Emanuele; CONNELLY, Patrick, R.; MOE, Scott, T.; ALI, Janid, A.; ALA, Paul, J.

Pub. Number AU-A-2002320184

PCT Number PCT/US02/20465

PCT Pub. Number WO2003/002063

Priority 60/301,676 28.06.01 US

Filing date 28 June 2002

Wipo publication date 3 March 2003

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/301,676 28.06.01 US

15 May 2003 Application Open to Public Inspection

  Published as AU-A-2002320184

3 March 2005 Assignment before Grant

  Essential Therapeutics, Inc.; Pliva d.d. The application has been assigned to PLIVA d.d.

7 February 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002320185-BIOLOGICAL ACTIVITY OF AK155

2002320183-BRIDGED TRICYCLIC ANALOGS OF 2-(CARBOXYCYCLOPROPYL)GLYCIN E AS INHIBITORS OF GLUTAMATE TRANSPORT